Tumors of the Sellar Region: Craniopharyngioma
Current Clinical Trials
Craniopharyngioma (World Health Organization grade I) is often curable. (Refer to the Tumors of the Sellar Region section in the Classification section of this summary for more information.)
Standard treatment options:
- Surgery alone if the tumor is totally resectable.[1]
- Debulking surgery plus radiation therapy if the tumor is unresectable.[2]
Current Clinical Trials
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with adult craniopharyngioma. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.
General information about clinical trials is also available from the NCI Web site.
References
-
Baskin DS, Wilson CB: Surgical management of craniopharyngiomas. A review of 74 cases. J Neurosurg 65 (1): 22-7, 1986.
[PUBMED Abstract]
-
Rajan B, Ashley S, Gorman C, et al.: Craniopharyngioma--a long-term results following limited surgery and radiotherapy. Radiother Oncol 26 (1): 1-10, 1993.
[PUBMED Abstract]
Back to Top
< Previous Section | Next Section > |